AstraZeneca's Christine Foster on CRT Trends & Quality Control




"We have just started our journey, and I think we are going to continue to drive that performance." Christine Foster, AstraZeneca

Maryann Gribbin, Director of Quality Assurance at Johnson & Johnson interviews Christine Foster, Global QA Audit Manager for AstraZeneca about the trends she is witnessing in the global shipments of Controlled Room Temperature (CRT) products, strategies for risk mitigation and shortening the learning curve.

This video was filmed at the 10th Anniversary Cold Chain & Temperature Management Global Forum 
[eventpdf]

Have Your Say
Rate this feature and give us your feedback in the comments section below

"We have just started our journey, and I think we are going to continue to drive that performance." Christine Foster, AstraZeneca

Maryann Gribbin, Director of Quality Assurance at Johnson & Johnson interviews Christine Foster, Global QA Audit Manager for AstraZeneca about the trends she is witnessing in the global shipments of Controlled Room Temperature (CRT) products, strategies for risk mitigation and shortening the learning curve.